Near-complete Response of Bilateral Adrenal Metastases to 177Lu-PSMA Therapy in Castration-resistant Prostate Cancer on Posttherapeutic SPECT-CT Follow Up. (PubMed, Clin Nucl Med) - Oct 10, 2026 - "As the patient was oligometastatic, refractory to previous systemic therapies, and ineligible for surgery or radiotherapy, 177Lu-PSMA-617 radioligand therapy was initiated. After four treatment cycles, PSA levels progressively decreased, and post-therapeutic follow-up SPECT/CT demonstrated a near-complete response in adrenal and bone metastases without treatment-related adverse effects."
Journal • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|
|
Burcak Yilmaz; Emre Özcan; Esra Civriz; Gulhan Ozkanli; Ilkmen Nesrin Aslan; Zeynep Hudayioglu
|